Journal of the Formosan Medical Association
Volume 108, Issue 11 , Pages 872-878, November 2009

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors

  • Chen-Hsun Ho

      Affiliations

    • Department of Urology, Taipei, Taiwan
    • Division of Urology, Department of Surgery, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
  • ,
  • Chao-Yuan Huang

      Affiliations

    • Department of Urology, Taipei, Taiwan
  • ,
  • Wei-Chou Lin

      Affiliations

    • Pathology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
  • ,
  • Shih-Chieh Chueh

      Affiliations

    • Department of Urology, Taipei, Taiwan
  • ,
  • Yeong-Shiau Pu

      Affiliations

    • Department of Urology, Taipei, Taiwan
  • ,
  • Ming-Kuen Lai

      Affiliations

    • Department of Urology, Taipei, Taiwan
  • ,
  • Hong-Jeng Yu

      Affiliations

    • Department of Urology, Taipei, Taiwan
  • ,
  • Kuo-How Huang

      Affiliations

    • Department of Urology, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Kuo-How Huang, Department of Urology, National Taiwan University Hospital and College of Medicine, 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 21 December 2008; received in revised form 3 March 2009; accepted 20 April 2009.

Article Outline

Background/Purpose

To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyzed our data and reported the oncological outcomes and survival predictors.

Methods

Patients underwent radical cystectomy for bladder transitional cell carcinoma between March 1995 and July 2007 were evaluated. The clinical course, pathological characteristics, and clinical outcomes were described and analyzed.

Results

A total of 148 patients (98 men and 50 women) with a median age of 66.7 years (range: 23.8–83.3) were included in the study. Median follow-up was 64 months. The perioperative mortality was 2.7%. The 5-year recurrence-free survival (RFS) and overall survival (OS) for all 148 patients was 61% and 53%, respectively. The 5-year RFS and OS were 68% and 62% for pT2, 65% and 59% for pT3, 11% and 9% for pT4, and 37% and 31% for nodal-positive disease, respectively. The number of positive lymph nodes was significantly associated with survival: 5-year RFS and OS were 54% and 33%, for patients with only 1–3 positive lymph nodes, whereas, all patients with ≥4 positive lymph nodes had recurrence. On multivariate analysis, age > 60 years, pT4 tumors, and lymph node involvement had a negative impact on survival.

Conclusion

Radical cystectomy can be curative in a significant portion of patients with organ-confined (T2 or less) and extravesical (pT3) bladder cancer. Age > 60 years, pT4 tumors, and nodal metastases were associated with poor prognosis. Patients with limited lymph node involvement (1–3 nodes) can be cured by surgery alone, whereas a more extensive lymph node metastasis (≥ 4 nodes) eventually results in recurrence. Concomitant prostate cancer is of low grade and early stage, and is clinically insignificant.

Key Words:  bladder cancer , cystectomy , lymph nodes , neoplasm metastasis , survival

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Bureau of Health Promotion, Executive Yuan, Taiwan, R.O.C. Cancer Registry Annual Report, 2005. Taipei: Bureau of Health Promotion, Department of Health, Executive Yuan, Taiwan, R.O.C.
  2. American Joint Committee on Cancer  . In: Cancer Staging Manual . 5th ed.. Philadelphia: Lippincott–Raven; 1997;p. 241
  3. Herr HW , Dotan Z , Donat SM , et al.   Defining optimal therapy for muscle invasive bladder cancer . J Urol . 2007;177:437–443
  4. Stein JP , Lieskovsky G , Cote R , et al.   Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients . J Clin Oncol . 2001;19:666–675
  5. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis . Lancet . 2003;361:1927–1934
  6. Grossman HB , Natale RB , Tangen CM , et al.   Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer . N Engl J Med . 2003;349:859–866
  7. Herr HW , Faulkner JR , Grossman HB , et al.   Surgical factors influence bladder cancer outcomes: a cooperative group report . J Clin Oncol . 2004;22:2781–2789
  8. Herr HW . The concept of lymph node density: is it ready for clinical practice? . J Urol . 2007;177:1273–1276
  9. Herr HW , Bochner BH , Dalbagni G , et al.   Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer . J Urol . 2002;167:1295–1298
  10. Steven K , Poulsen AL . Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only . J Urol . 2007;178:1214–1218
  11. Poulsen AL , Horn T , Steven K . Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall . J Urol . 1998;160:2015–2020
  12. Daughtry JD , Susan LP , Stewart BH , et al.   Ileal conduit and cystectomy: a 10-year retrospective study of ileal conduits performed in conjunction with cystectomy and with a minimum 5-year followup . J Urol . 1977;118:556–557
  13. Lerner SP , Skinner DG , Lieskovsky G , et al.   The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results . J Urol . 1993;149:755–758
  14. Vieweg J , Whitmore WF , Herr HW , et al.   The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan– Kettering Cancer Center experience . Cancer . 1994;73:3020–3028
  15. Vieweg J , Gschwend JE , Herr HW , et al.   Pelvic lymph node dissection can be curative in patients with node positive bladder cancer . J Urol . 1999;161:449–454
  16. Yang CR , Ou YC , Ho HC , et al.   Unsuspected prostate carcinoma and prostatic intraepithelial neoplasm in Taiwanese patients undergoing cystoprostatectomy . Mol Urol . 1999;3:33–39

PII: S0929-6646(09)60419-8

doi:10.1016/S0929-6646(09)60419-8

Journal of the Formosan Medical Association
Volume 108, Issue 11 , Pages 872-878, November 2009